Publications - Michael W. Stewart, M.D.

Back to research profile

  1. Stewart MW. Herpetic (Non-Cytomegalovirus) Retinal Infections In Patients With The Acquired Immunodeficiency Syndrome. Curr HIV Res. 2013 Apr 01. [Epub ahead of print]
    View PubMed
  2. Smith CD, Spackman T, Brommer K, Stewart MW, Vizzini M, Frye J, Rupp WC. Re-engineering the operating room using variability methodology to improve health care value. J Am Coll Surg. 2013 Apr; 216(4):559-68; discussion 568-70.
    View PubMed
  3. Stewart MW, Gonzalez S, Rosenfeld PJ, Brown J, Murphy SP. To the editor. Retina. 2013 Mar; 33(3):669-70.
    View PubMed
  4. Stewart MW. Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration. Expert Rev Clin Pharmacol. 2013 Mar; 6(2):103-13.
    View PubMed
  5. Stewart MW, Bolling JP, Bendel RE. Nocardia brasiliensis endophthalmitis in a patient with an exposed Ahmed glaucoma drainage implant. Ocul Immunol Inflamm. 2013 Feb; 21(1):54-5.
    View PubMed
  6. Stewart MW, Stewart ML. Topical azithromycin or ofloxacin for endophthalmitis. Clin Ophthalmol. 2013; 7:35-6. Epub 2012 Dec 31.
    View PubMed
  7. Stewart MW. Review of aflibercept for the treatment of neovascular age-related macular degeneration. Clinical Medicine Insights: Therapeutics. 2013; 5:81-93.
  8. Stewart MW. Aflibercept as a treatment for age-related macular degeneration. US Ophthalmic Reviews. 2013; 6(1):58-63.
  9. Forlenza GP, Stewart MW. Diabetic retinopathy in children. Pediatr Endocrinol Rev. 2012 Dec-2013 Jan; 10(2):217-26.
    View PubMed
  10. Stewart MW. Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug. Br J Ophthalmol. 2012 Sep; 96(9):1157-8. Epub 2012 Mar 23.
    View PubMed
  11. Stewart MW. Corticosteroid use for diabetic macular edema: old fad or new trend? Curr Diab Rep. 2012 Aug; 12(4):364-75.
    View PubMed
  12. Browning DJ, Kaiser PK, Rosenfeld PJ, Stewart MW. Aflibercept for age-related macular degeneration: a game-changer or quiet addition? Am J Ophthalmol. 2012 Aug; 154(2):222-6.
    View PubMed
  13. Stewart MW. Anti-vascular endothelial growth factor drug treatment of diabetic macular edema: the evolution continues. Curr Diabetes Rev. 2012 Jul 1; 8(4):237-46.
    View PubMed
  14. Butendieck RR, Parikh K, Stewart M, Davidge-Pitts C, Abril A. Systemic lupus erythematosus-associated retinal vasculitis. J Rheumatol. 2012 May; 39(5):1095-6.
    View PubMed
  15. Stewart MW, Rosenfeld PJ, Penha FM, Wang F, Yehoshua Z, Bueno-Lopez E, Lopez PF. Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye). Retina. 2012 Mar; 32(3):434-57.
    View PubMed
  16. Gonzalez S, Rosenfeld PJ, Stewart MW, Brown J, Murphy SP. Avastin doesn't blind people, people blind people. Am J Ophthalmol. 2012 Feb; 153(2):196-203.e1.
    View PubMed
  17. Stewart MW. The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clin Proc. 2012 Jan; 87(1):77-88.
    View PubMed
  18. Stewart MW. Vascular endothelial growth factor (VEGF) biochemistry and development of inhibitory drugs. Current Drug Therapy. 2012; 7(2):80-9.
  19. Stewart MW. Vascular endothelial growth factor inhibitor use in ophthalmology: The revolution continues. Current Drug Therapy. 2012; 7(2):77-9.
  20. Stewart MW. Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept. Clin Ophthalmol. 2012; 6:1175-86. Epub 2012 Jul 26.
    View PubMed
  21. Stewart MW. Pharmacokinetics of intravitreal anti-VEGF agents: practical clinical implications. Intervitreal Interventions. 2012; 1(1):1-4.
  22. Vanner EA, Stewart MW, Liesegang TJ, Bendel RE, Bolling JP, Hasan SA. A retrospective cohort study of clinical outcomes for intravitreal crystalline retained lens fragments after age-related cataract surgery: a comparison of same-day versus delayed vitrectomy. Clin Ophthalmol. 2012; 6:1135-48. Epub 2012 Jul 18.
    View PubMed
  23. Stewart MW. Unilateral vision loss following contralateral eye treatment. Intravitreal Interventions. 2012; 1(2):13.
  24. Stewart MW. Human immunodeficiency virus and its effects on the visual system. Infectious Disease Reports. 2012; 4(1):92-100.
  25. Stewart MW. New anti-VEGF antibody therapies in Ophthalmology. Curr Med Literature - Ophthalmology. 2012; 22(4):105-113.
  26. Stewart MW. Early experience using aflibercept in the treatment of wet macular degeneration. Intravitreal Interventions. 2012; 1(4):1-11.
  27. Stewart MW. Aflibercept (VEGF-TRAP): the next anti-VEGF drug. Inflamm Allergy Drug Targets. 2011 Dec; 10(6):497-508.
    View PubMed
  28. Davis J, Olsen TW, Stewart M, Sternberg P Jr. How the comparison of age-related macular degeneration treatments trial results will impact clinical care. Am J Ophthalmol. 2011 Oct; 152(4):509-14.
    View PubMed
  29. Vanner EA, Stewart MW. Vitrectomy timing for retained lens fragments after surgery for age-related cataracts: a systematic review and meta-analysis. Am J Ophthalmol. 2011 Sep; 152(3):345-357.e3. Epub 2011 Jun 17.
    View PubMed
  30. Stewart MW. Impact of HIV on vision. Northeast Florida Medicine. 2011; 62(2):3-8.
  31. Stewart MW, Vavra MW, Whaley NR. Fundus findings in a patient with [alpha]-methylacyl-CoA racemase deficiency. Retinal Cases and Brief Reports. 2011; 5(3):262-266.
  32. Stewart MW. What are the half-lives of ranibizumab, aflibercept (VEGF Trap-eye) in human eyes? Calculations with a mathematical model. Eye Reports. 2011; 1(1):12-14.
  33. Stewart MW. Optimal management of cytomegalovirus retinitis in patients with AIDS. Clin Ophthalmol. 2010; 4:285-99. Epub 2010 Apr 26.
    View PubMed
  34. Stewart MW, Rosenfeld PJ. Predicted biological activity of intravitreal VEGF Trap. Br J Ophthalmol. 2008 May; 92(5):667-8. Epub 2008 Mar 20.
    View PubMed
  35. Stewart MW. Predicted biologic activity of intravitreal bevacizumab. Retina. 2007 Nov-Dec; 27(9):1196-200.
    View PubMed
  36. Shetty RK, Boilling JP, Stewart MW, Heckman MG. Differences in optical coherence tomography of the macula in advanced glaucoma and after a retinal artery occlusion. Ophthalmic Surg Lasers Imaging. 2007 Sep-Oct; 38(5):392-8.
    View PubMed
  37. Stewart MW, Brazis PW, Guier CP, Thota SH, Wilson SD. Purtscher-like retinopathy in a patient with HELLP syndrome. Am J Ophthalmol. 2007 May; 143(5):886-7.
    View PubMed
  38. Hasan SA, Stewart MW. Cystoid macular edema following photorefractive keratectomy complicated by presumptive infectious keratitis. J Cataract Refract Surg. 2007 Feb; 33(2):348-9.
    View PubMed
  39. Stewart MW. Intravitreal bevacizumab (avastin) for the treatment of chorioretinal vascular diseases. Techniques in Ophthalmology. 2007; 5(1):40-5.
  40. Stewart MW, Alvarez S, Ginsburg WW, Shetty R, McLain WC, Sleater JP. Visual recovery following Mycobacterium chelonae endophthalmitis. Ocul Immunol Inflamm. 2006 Jun; 14(3):181-3.
    View PubMed
  41. Hellinger WC, Hasan SA, Bacalis LP, Thornblom DM, Beckmann SC, Blackmore C, Forster TS, Tirey JF, Ross MJ, Nilson CD, Mamalis N, Crook JE, Bendel RE, Shetty R, Stewart MW, Bolling JP, Edelhauser HF. Outbreak of toxic anterior segment syndrome following cataract surgery associated with impurities in autoclave steam moisture. Infect Control Hosp Epidemiol. 2006 Mar; 27(3):294-8. Epub 2006 Feb 22.
    View PubMed
  42. Stewart MW, Landers MB 3rd. Transscleral intraocular lens fixation with a "homemade" needle and hook. J Cataract Refract Surg. 2006 Feb; 32(2):200-2.
    View PubMed
  43. Stewart MW, Liesegang TJ, Schwam BL. Chlamydia conjunctivitis and central retinal vein occlusion. Am J Ophthalmol. 2005 Jul; 140(1):161-2.
    View PubMed
  44. Stewart MW, Brazis PW, Barrett KM, Eidelman BH, Mendez JC. Optical coherence tomography in a case of bilateral neuroretinitis. J Neuroophthalmol. 2005 Jun; 25(2):131-3.
    View PubMed
  45. Stewart MW. Intraoperative radiographic detection of a "lost" scleral plug. Retina. 2005 Jun; 25(4):526-7.
    View PubMed
  46. Stewart MW, Bolling JP, Mendez JC. Cytomegalovirus retinitis in an immunocompetent patient. Arch Ophthalmol. 2005 Apr; 123(4):572-4.
    View PubMed
  47. Stewart MW. Treatment of an avulsed retinal vessel with infrared diode laser photocoagulation. Am J Ophthalmol. 2004 Apr; 137(4):767-8.
    View PubMed
  48. Brazis PW, Stewart M, Lee AG. The uveo-meningeal syndromes. Neurologist. 2004; 10(4):171-84.
    View PubMed
  49. Brazis PW, Lee AG, Stewart M, Capobianco D. Clinical review: The differential diagnosis of pain in the quiet eye. Neurologist. 2002; 8(2):82-100.
    View PubMed
  50. Stewart MW. Choroidal melanoma. Jacksonville Medicine. 2000; 51:393-399.
  51. Stewart MW, Lambrou FH Jr. AIDS Retinopathy. Jacksonville Medicine. 1997; 48:347-51.
  52. Stewart MW, Lambrou FH Jr, Watson M. Intravitreal ganciclovir injections for the treatment of cytomegalovirus retinitis. Ophthalmology. 1997; 104(Suppl):S149.
    View PubMed
  53. Skowsky WR, Siddiqui T, Hodgetts D, Lambrou FH, Stewart MW, Foster MT Jr. A pilot study of chronic recombinant interferon-alfa 2a for diabetic proliferative retinopathy: metabolic effects and ophthalmologic effects. J Diabetes Complications. 1996; 10(2):94-9.
    View PubMed
  54. Stewart MW. Update on CMV retinitis. Review of Ophthalmol. 1994 Nov:5-52.
  55. Pogrebniak AE, Bolling JP, Stewart MW. Argon laser-induced cataract in an infant with retinopathy of prematurity. Am J Ophthalmol. 1994 Feb 15; 117(2):261-2.
    View PubMed
  56. Friedman SM, Mames RN, Stewart MW. Subretinal hemorrhage after grid laser photocoagulation for idiopathic juxtafovealar retinal telangiectasis. Ophthalmol Surg. 1993; 24:551-3.
  57. Lambrou FH Jr, Stewart MW. Management of dislocated lens fragments during phacoemulsification. Ophthalmology. 1992 Aug; 99(8):1260-2; discussion 1268-9.
    View PubMed
  58. Stewart MW, Lambrou FH Jr. Management of dislocated lens fragments: Pars plana vitrectomy and transscleral fixation of posterior chamber lens implants. Vitreoretinal Surg and Tech. 1992; 4(3):5-6.
  59. Hjelmeland LM, Stewart MW, Li J, Toth CA, Burns MS, Landers MB III. An experimental model of ectropion uveae and iris neovascularization in the cat. Invest Ophthalmol Vis Sci. 1992; 33(5):1796-803.
    View PubMed
  60. Landers MBL III, Stewart MW, Maberely D, Serdahl C. A new inexpensive pump for vitreoretinal surgery. Arch Ophthalmol. 1991; 109:142-3.
    View PubMed
  61. Arora N, Lambrou FH Jr, Stewart MW, et al. Sudden blindness associated with central nervous symptoms in a hemodialysis patient. Nephron. 1991; 59:490-2.
    View PubMed
  62. Lambrou FH, Stewart MW. Management of dislocated lens fragments. Ophthalmol. 1991; 98(Suppl 8):169.
  63. Sternberg P Jr, Meredith TA, Stewart MW, Kaplan HJ. Retinal detachment in penetrating keratoplasty patients. Am J Ophthalmol. 1990; 109:148-52.
    View PubMed
  64. Stewart MW, Lambrou FH Jr. Lasers and retina surgery. Jacksonville Medicine. 1990; 41:448-50.
  65. Stewart MW, Gitter KA, Cohen G. Acute leukemia presenting as a unilateral exudative retinal detachment. Retina. 1989; 9:110-4.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.